Royalty Pharma plc (RPRX) is higher by Monday morning, with the stock adding 2.26% in pre-market trading to 42.5. RPRX's short-term technical score of 55 indicates that the stock has traded more bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 138 out of 146 industries, Royalty Pharma plc ranks higher than 84% of stocks. Royalty Pharma plc has risen 10.83% over the past month, closing at $37.67 on October 25. During this period of time, the stock fell as low as $36.81 and as high as $43.68. RPRX has an average analyst recommendation of Strong Buy. The company has an average price target of $51.71.
News Home
Royalty Pharma plc has a Long-Term Technical rank of 37. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 63% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, RPRX ranks better than 63% of stocks.
Premarket Mover: Royalty Pharma plc (RPRX) Up 2.26%
Mentioned in this article
RPRX has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on RPRX!